Odronextamab Biosimilar – Research Grade
- Sizes: 0.1mg, 5mg, 10mg, 20mg, 50mg
- Category: ichorbio, Low endotoxin, biosimilar antibody, bispecific
- Target: CD3/CD20
- Clone:
- Host:
-
Datasheet
Tech Support
PRODUCT DETAILS
SPECIFICATIONS |
|
|---|---|
|
PRODUCT NAME |
Odronextamab Biosimilar - Research Grade |
|
SPECIES REACTIVITY |
Human |
|
HOST |
|
| SPECIFICITY |
Detects human CD3/CD20. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Odronextamab. This product is for research use only. |
| PURIFICATION METHOD |
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| ANTIGEN DISTRIBUTION |
|
| IMMUNOGEN |
|
| CONCENTRATION |
|
| FORMULATION |
Sterile, preservative-free, solution in PBS. BSA and Azide free. |
| PURITY |
>95% by SDS-PAGE |
| ENDOTOXIN |
≤ 1.0 EU/mg as determined by the LAL method |
| AGGRIGATION |
|
| STORAGE CONDITION |
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
TARGET |
|
|---|---|
| TARGET |
CD3/CD20 |
| CLONE |
|
| SYNONYMS |
|
| BACKGROUND |
ichorbio’s Mosunetuzumab biosimilar Odronextamab is a hinge-stabilized, fully human IgG4-based CD3 x CD20 bispecific antibody (bsAb) that has demonstrated encouraging safety, tolerability and preliminary efficacy in a first-in-human study of patients with relapsed/refractory B-cell non-Hodgkin lymphoma. |
| UNIPROT |
|
| PATHOGEN TEST |
|
| APPLICATIONS |
Functional Assays |
| APPLICATION NOTES |
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients. |
| USAGE |
Products are for research use only. Not for use in diagnostic or therapeutic procedures. |